세계의 듀얼 챔버형 프리필드 시린지 시장 예측 : 제품 유형별, 적응증별, 재료별, 유통 경로별, 용도별, 지역별 분석(-2030년)

According to Stratistics MRC, the Global Dual Chamber Prefilled Syringes Market is accounted for $168.72 million in 2023 and is expected to reach $304.48 million by 2030 growing at a CAGR of 8.8% during the forecast period. Dual Chamber Prefilled syringes, which provide a simplified method for the easy administration of two different substances, mark a substantial advancement in drug delivery technology. There are two compartments on these syringes, and inside are separate components or medications. Drugs can be stored separately and mixed simultaneously thanks to the design, which maintains the drug's potency and stability until injection time. Moreover, this novel approach is especially useful in situations where the combination of two drugs is necessary for a given therapeutic effect.

According to the International Pharmaceutical Excipients Council (IPEC), dual chamber prefilled syringes represent a significant advancement in drug delivery technology. These syringes feature two separate chambers, typically designed to store and isolate different components, such as a drug and a diluent.

Market Dynamics:

Driver:

Improved medicine stability

Dual-chamber prefilled syringes are essential for resolving issues with stability that come with some medications. These syringes avoid premature mixing that can cause degradation by keeping individual drug components apart until the point of administration. Additionally, this feature is especially important for medications that are prone to physical or chemical instability because it guarantees that patients receive their medications in the best possible state, which improves therapeutic outcomes.

Restraint:

Intricate manufacturing procedures

Dual-chamber prefilled syringes have benefits, but complicated manufacturing procedures present some difficulties. Production costs may rise as a result of the complex construction and assembly of these syringes, which entails guaranteeing appropriate component isolation and upholding structural integrity overall. Furthermore, these intricacies must be resolved by manufacturers in order to maximize production efficiency and cost-effectiveness, which may have an effect on the general use of dual-chamber prefilled syringes.

Opportunity:

Individualization for particular drug formulations

One major opportunity to the market is the ability to tailor dual-chamber prefilled syringes to the unique needs of various drug formulations. Manufacturers and pharmaceutical companies can collaborate closely to create syringes that are specifically designed to meet the needs of various medications. Moreover, this personalization can improve dual chamber syringes' suitability and efficiency for a variety of medications, encouraging cooperation and alliances in the pharmaceutical sector.

Threat:

Market saturation and the competitive environment

There is a risk of growing competition and eventual market saturation in the dual-chamber prefilled syringe market. There's a chance that oversaturation will result in price wars and narrower profit margins as more manufacturers enter the market. Additionally, to remain competitive and effectively navigate potential market saturation, companies need to differentiate their products through innovation, quality, and strategic partnerships.

Covid-19 Impact:

The market for dual-chamber prefilled syringes has experienced both opportunities and challenges as a result of the COVID-19 pandemic. On the one hand, prefilled syringes, including dual chamber models, are in high demand due to the increased focus on vaccination campaigns around the globe. These syringes offer accurate and efficient drug delivery for vaccines. But there have been difficulties due to manufacturing hold-ups, disruptions in global supply chains, and increased scrutiny of healthcare spending. Furthermore, the pandemic has accelerated the adoption of novel drug delivery solutions and highlighted the significance of robust supply chains.

The Diabetes segment is expected to be the largest during the forecast period

In the market for dual-chamber prefilled syringes, the diabetes segment is predicted to hold the largest share. Global diabetes prevalence has increased demand for accurate and practical drug delivery systems. Prefilled syringes with two chambers are especially useful for diabetics who need to mix the components of insulin or reconstitute medications before administering them. Moreover, these syringes provide better accuracy, lower the possibility of dosage mistakes, and increase patient compliance with insulin schedules.

The Plastic segment is expected to have the highest CAGR during the forecast period

In the dual chamber prefilled syringe market, the plastic segment has shown the highest CAGR. Numerous factors contribute to this growth. Because of their inherent flexibility, plastic prefilled syringes have advantages like better break resistance, a lower chance of glass breaking, and increased safety. Additionally, plastic syringes are simpler to handle and carry. Furthermore, it's common knowledge that plastic syringes are less expensive than glass syringes. The strong expansion of the plastic segment in this market has been attributed to the growing need for dual chamber prefilled syringes in a variety of applications, including veterinary medicine, biotechnology, and pharmaceuticals.

Region with largest share:

In the market, North America holds the largest share. The market in this area has grown significantly as a result of various factors. North America leads this market because of its well-established biotechnology and pharmaceutical sectors, as well as its emphasis on cutting-edge medical technologies and healthcare infrastructure. Additionally, the adoption of dual-chamber prefilled syringes in the region has also been aided by increased investment in research and development activities and a strong demand for novel drug delivery systems.

Region with highest CAGR:

The dual chamber prefilled syringe market has shown the highest CAGR in the Asia-Pacific region. Numerous elements have played a role in the remarkable expansion of the area. Rapid economic development in the Asia-Pacific area has resulted in better healthcare infrastructure and higher healthcare spending. The need for sophisticated drug delivery devices, such as dual-chamber prefilled syringes, has therefore increased. Moreover, the aging population, increased prevalence of chronic illnesses, and growing knowledge of the advantages of prefilled syringes have all contributed to the region's market expansion.

Key players in the market

Some of the key players in Dual Chamber Prefilled Syringes market include Gerresheimer AG, Medtronic, Bayer AG, Nipro Corporation, Elcam Drug Delivery Devices, Pfizer Inc., Novartis AG, AbbVie Inc., Mylan N.V., Otsuka America Pharmaceutical, Inc., Credence MedSystems Inc., Vetter Pharma-Fertigung GmbH & Co. KG, Maeda Industry Co. Ltd., Catalent, Inc., Terumo Europe NV, West Pharmaceutical Services, Inc. and Schott AG.

Key Developments:

In February 2024, Bayer AG (BAYRY), a leading global pharmaceutical and biotechnology company, and TetraScience, the Scientific Data and AI Cloud company, announced an agreement aimed at maximizing the value of scientific data and driving innovation. This collaboration will support Bayer's mission to deliver the next generation of life-changing therapeutics and ensure global food security.

In November 2023, Gerresheimer held a groundbreaking ceremony at its glass facility in in Queretaro, Mexico to celebrate the start of construction for its plant expansion.The pharmaceutical and cosmetics glass manufacturer will invest approximately €100 million in a new building and new production lines at its Queretaro plant. This will increase its manufacturing capacity for syringes for the North American market by several hundred million "ready-to-fill" (RTF) syringes annually.

In May 2023, Medtronic plc, a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd., manufacturer of the EOPatch(R) device - a tubeless, wearable and fully disposable insulin delivery device. The addition of EOFlow, together with Medtronic's Meal Detection Technology(TM) algorithm and next-generation continuous glucose monitor, is expected to expand the company's ability to address the needs of more individuals with diabetes, no matter where they are in their treatment journey or preference for how they want their insulin delivered.

Product Types Covered:

• Conventional Prefilled Syringes
• Safety Prefilled Syringes
• Other Product Types

Types Covered:

• <1 ml
• 1 ml-2.5 ml
• 2.5 ml-5.0 ml
• >5.0 ml
• Other Types

Indications Covered:

• Hemophilia
• Schizophrenia
• Diabetes
• Erectile Dysfunction
• Endometriosis
• Other Indications

Materials Covered:

• Glass
• Plastic
• Other Materials

Distribution Channels Covered:

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies

Applications Covered:

• Liquid/Powder
• Liquid/Liquid
• Liquid/Lyophilisate
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Dual Chamber Prefilled Syringes Market, By Product Type

• 5.1 Introduction
• 5.2 Conventional Prefilled Syringes
• 5.3 Safety Prefilled Syringes
• 5.4 Other Product Types

6 Global Dual Chamber Prefilled Syringes Market, By Type

• 6.1 Introduction
• 6.2 <1 ml
• 6.3 1 ml-2.5 ml
• 6.4 2.5 ml-5.0 ml
• 6.5 >5.0 ml
• 6.6 Other Types

7 Global Dual Chamber Prefilled Syringes Market, By Indication

• 7.1 Introduction
• 7.2 Hemophilia
• 7.3 Schizophrenia
• 7.4 Diabetes
• 7.5 Erectile Dysfunction
• 7.6 Endometriosis
• 7.7 Other Indications

8 Global Dual Chamber Prefilled Syringes Market, By Material

• 8.1 Introduction
• 8.2 Glass
• 8.3 Plastic
• 8.4 Other Materials

9 Global Dual Chamber Prefilled Syringes Market, By Distribution Channel

• 9.1 Introduction
• 9.2 Hospitals Pharmacies
• 9.3 Retail Pharmacies
• 9.4 Online Pharmacies

10 Global Dual Chamber Prefilled Syringes Market, By Application

• 10.1 Introduction
• 10.2 Liquid/Powder
• 10.3 Liquid/Liquid
• 10.4 Liquid/Lyophilisate
• 10.5 Other Applications

11 Global Dual Chamber Prefilled Syringes Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Gerresheimer AG
• 13.2 Medtronic
• 13.3 Bayer AG
• 13.4 Nipro Corporation
• 13.5 Elcam Drug Delivery Devices
• 13.6 Pfizer Inc.
• 13.7 Novartis AG
• 13.8 AbbVie Inc.
• 13.9 Mylan N.V.
• 13.10 Otsuka America Pharmaceutical, Inc.
• 13.11 Credence MedSystems Inc.
• 13.12 Vetter Pharma-Fertigung GmbH & Co. KG
• 13.13 Maeda Industry Co. Ltd.
• 13.14 Catalent, Inc.
• 13.15 Terumo Europe NV
• 13.16 West Pharmaceutical Services, Inc.
• 13.17 Schott AG